Stephens Consulting’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Stephens Consulting’s Portfolio NURO Stock Details NURO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-62	Closed	-$247	–	554
2024 Q3	$247	Hold	62	–	–	﹤0.01%	504
2024 Q2	$229	Hold	62	–	–	﹤0.01%	638
2024 Q1	$264	Hold	62	–	–	﹤0.01%	463
2023 Q4	$224	Sell	62 -1	-2%	-$4	﹤0.01%	473
2023 Q3	$359	Hold	63	–	–	﹤0.01%	479
2023 Q2	$488	Hold	63	–	–	﹤0.01%	479
2023 Q1	$735	Hold	63	–	–	﹤0.01%	496
2022 Q4	$745	Hold	63	–	–	﹤0.01%	469
2022 Q3	$1.4K	Hold	63	–	–	﹤0.01%	506
2022 Q2	$1.84K	Hold	63	–	–	﹤0.01%	481
2022 Q1	$2.08K	Sell	63 -62	-50%	-$2.21K	﹤0.01%	500
2021 Q4	$5.02K	Buy	+125	New	+$7.39K	﹤0.01%	477

Other funds holding NURO

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

TAM

Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

Stephens Consulting's NURO Position: Q4 2024 in Review

Stephens Consulting sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2024, closing a stake of 62 shares — an estimated $247 sold.

Stephens Consulting first reported a position in NURO in Q4 2021 and held it in 12 quarters. The position peaked at $5.02K in Q4 2021. 16 funds tracked by Wall St. Rank hold NURO as of Q4 2024.

Stephens Consulting reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Stephens Consulting sold 62 NeuroMetrix, Inc. Common Stock shares in Q4 2024, an estimated $247.
Stephens Consulting first reported a position in NeuroMetrix, Inc. Common Stock in Q4 2021 and held it in 12 quarters.
Stephens Consulting's NeuroMetrix, Inc. Common Stock position peaked at $5.02K in Q4 2021.
16 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2024.

Based on Stephens Consulting's 13F filing for Q4 2024, filed 27 Jan 2025.